🇺🇸 FDA

Company profile · Sponsor

Akeso

C766CF0 · NMPA pharma CN
Pipeline
3
Drugs
0
Patents
0

Quick answer

Akeso (C766CF0) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C766CF0
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (3)

Search pipeline →

  1. AK104

    Akeso

    Advanced Malignant Tumors

    phase 2 small molecule active

    1 trial

  2. AK112, Cadonilimab, nab-paclitaxel, gemcitabine

    Akeso

    Metastatic Pancreatic Ductal Adenocarcinoma

    phase 2 small molecule active

    1 trial

  3. AK120 or placebo- Part 1- Cohort 1

    Akeso

    Atopic Dermatitis

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is Akeso?

Akeso (C766CF0) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Akeso sponsor?

We track 3 ClinicalTrials.gov-linked programs for Akeso, including AK104 and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Akeso company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.